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Background: Many studies have assessed the efficacy of radiofrequency ablation to denervate 
the facet joint as an interventional means of treating axial low-back pain. In these studies, vary-
ing procedural techniques were utilized to ablate the nerves that innervate the facet joints. To 
date, no comparison studies have been performed to suggest superiority of one technique or 
even compare the prevalence of side effects and complications.
Materials and methods: A retrospective chart review was performed on patients who under-
went a lumbar facet denervation procedure. Each patient’s chart was analyzed for treatment 
technique (early versus advanced Australian), preprocedural visual numeric scale (VNS) score, 
postprocedural VNS score, duration of pain relief, and complications.
Results: Pre- and postprocedural VNS scores and change in VNS score between the two groups 
showed no significant differences. Patient-reported benefit and duration of relief was greater 
in the advanced Australian technique group (P=0.012 and 0.022, respectively). The advanced 
Australian technique group demonstrated a significantly greater median duration of relief 
(4 months versus 1.5 months, P=0.022). Male sex and no pain-medication use at baseline were 
associated with decreased postablation VNS scores, while increasing age and higher preabla-
tion VNS scores were associated with increased postablation VNS scores. Despite increasing 
age being associated with increased postablation VNS scores, age and the advanced Australian 
technique were found to confer greater patient self-reported treatment benefit.
Conclusion: The advanced Australian technique provides a significant benefit over the early 
Australian technique for the treatment of lumbar facet pain, both in magnitude and duration 
of pain relief.
Keywords: low-back pain, lumbar facet arthropathy, interventional pain management, radiof-
requency ablation
Introduction
Chronic pain is a widespread disorder with a prevalence of 2%–40% in the US. In 
individuals suffering from chronic pain, 28% complain of low-back pain.1 Excluding 
nonstructural causes of pain, low-back pain can arise from multiple areas: the inter-
vertebral discs of the spine, the zygapophysial (facet) joints of the spine, and the 
paravertebral muscles, ligaments, and fascia.2,3 Postmortem studies have revealed 
that intervertebral discs and zygapophysial joints exhibit the greatest degree of 
degeneration within the spine, thus indicating the potential role of these structures 
in causing low-back pain.4 In patients with a structural cause of low-back pain, 15% 
of cases arise from the lumbar facet joints.5,6 The etiology of lumbar facet-joint 
pain is thought to result from repetitive stress and trauma to the joint, leading to 
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inflammation and stretching of the joint capsule.6 Treatment 
options range from conservative management with the use 
of medications and physical therapy to interventional man-
agement with the use of intra-articular facet-joint injections 
and radiofrequency ablation of the nervous innervation to 
the facet joints.6–9
Multiple studies have been performed assessing the effi-
cacy of radiofrequency ablation to denervate the facet joint 
as an interventional means of treating low-back pain.10–14 In 
these studies, varying procedural techniques were utilized 
to ablate the nerves that innervate the facet joints. The early 
Australian technique described by Bogduk and Long in 1980 
targets the dorsal surface of the transverse process just caudal 
to the most medial end of the superior edge of the transverse 
process.15 The advanced Australian technique described by 
the International Spine Intervention Society uses a steep 
caudocephalad axial tilt of the fluoroscopy beam with a 20° 
lateral tilt to allow the radiofrequency-ablation needle to hug 
the anterolateral aspect of the base of the superior articular 
process.16 Multiple papers have detailed the anatomic course 
of the nerves that innervate the facet joints.15,17,18 A recent 
review compared the anatomic and technical accuracy of 
the different procedural techniques in treating lumbar facet 
arthropathy, and described the advanced Australian technique 
as being the most anatomically appropriate technique.19 
Currently, there is no available literature comparing the effi-
cacy of the early Australian versus the advanced Australian 
facet joint-denervation technique.
In this study, we sought to examine the efficacy of the 
early Australian technique and the advanced Australian 
technique in terms of patient pain relief, both quantita-
tive and subjective, as well as duration of relief. The rate 
of complications, the need for follow-up procedures, and 
whether patient factors affected outcomes were also assessed 
to determine which technique provided better patient safety 
and outcome.
Materials and methods
Study population
Prior to data collection, this retrospective chart review was 
approved by our institutional review board. Prior to retrospec-
tive chart review and data collection, the study was reviewed 
and approved by the Institutional Review Board at the Univer-
sity of California Los Angeles. Given the retrospective nature 
of the study and large patient cohort, an informed consent 
waiver was obtained. Patients who underwent lumbar facet 
radiofrequency denervation between the years of 2008 and 
2012 at our outpatient University Pain Management Clinic 
and presented for at least one follow-up encounter were 
identified and included in this study. As this study spans 4 
years, many individuals received repeat facet radiofrequency 
denervation procedures. To allow for a more appropriate 
comparison between the two radiofrequency denervation 
techniques and to better assess the baseline efficacy, only 
data for the initial facet radiofrequency denervation of each 
patient was used for analysis.
Procedural considerations
All procedures during the study time period were performed 
by American Board of Anesthesiology, Pain Medicine sub-
specialty board-certified, pain-management physicians, all 
of whom were fellowship-trained.
Patient selection in our practice commences with an 
in-person history and physical examination. Should the 
patient have a history and physical exam consistent with 
facet-related pain syndrome, it is standard practice at our 
facility to perform one set of diagnostic lumbar facet medial 
branch nerve blocks prior to proceeding with lumbar facet 
radiofrequency denervation. It is standard practice at our 
facility among all practitioners that the medial branch nerve 
block is performed with 1 mL of long-acting local anesthetic 
(0.25% bupivacaine) given through each needle. The two 
branches of medial branch nerves that innervate the facet 
joint are always targeted for both diagnostic blocks and 
denervation. At a follow-up visit shortly after the procedure, 
patients who reported greater than 75% pain reduction during 
the time frame that the local anesthetic was active were then 
considered to be candidates for the denervation procedure. 
All patients included in this study met this criteria prior to 
their denervation procedure.
Needle placement for the radiofrequency denervation pro-
cedure was performed using either the early Australian tech-
nique or the advanced Australian technique. Radiofrequency 
cannulas used for the procedure were either 18 or 20 gauge, 
with a 10 mm active tip. Technique after needle placement 
was consistent among all providers for all patients. After 
cannulas were placed, motor and/or sensory electrical test-
ing was used to confirm that the needle was not positioned 
near the spinal nerve or ventral ramus. Once this was con-
firmed, 1 mL of 1% lidocaine was given prior to lesioning 
through each cannula. Lesioning then took place at 80°C 
if an 18-gauge cannula was used and 90°C if a 20-gauge 
cannula was used, both for 90 seconds. After lesioning, 
1 mL of a solution containing 4 mL of 0.25% bupivacaine 
plus 1 mL of triamcinolone (40 mg/mL) was given through 
each cannula.
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Outcome measures
The patient’s age, sex, and ethnicity were collected for 
demographic purposes. Each patient’s chart was assessed to 
determine whether the patient underwent an early Australian 
versus advanced Australian facet radiofrequency denerva-
tion technique. Additionally, the lumbar levels at which 
each patient was treated with radiofrequency ablation were 
recorded. The primary outcome measures were 1-month 
postprocedure visual numeric scale (VNS) pain scores and 
VNS pain-score difference.20 Secondary outcome measures 
included: 1) patient self-reported improvement in pain fol-
lowing their radiofrequency denervation as noted in the 
patient’s medical records, 2) adverse reactions and events 
related to the procedure, 3) pain-medicine consumption prior 
to and after the procedure, 4) the need for any subsequent, 
nonfacet denervation, pain-related intervention for the treat-
ment of low-back pain, and 5) time to initial recurrence of a 
patient’s facet pain following radiofrequency denervation.
Patients that reported resolution of their pain at their 
1-month postprocedural clinic visit but were subsequently 
lost to follow-up were classified as having resolution of their 
pain. In these patients, the time frame between their radiofre-
quency denervation procedure and their last clinic visit was 
reported as the duration of pain relief. For all other patients, 
the duration of pain relief was determined from subsequent 
follow-up visits reporting recurrence of the patient’s lumbar 
facet pain.
Statistical analysis
To analyze the efficacy of the early Australian technique 
compared to the advanced Australian technique, Student’s 
t-tests were used to compare pre- and postablation VNS test 
scores as well as change in VNS test scores between groups. 
An assessment of the distribution of the VNS scores for the 
early Australian and advanced Australian techniques was 
performed to ensure a Gaussian distribution. To compare 
the subjective benefit rates reported between patients of the 
two groups, a χ2 test was performed. As the duration of relief 
between the two groups did not follow a normal distribution, a 
Wilcoxon rank-sum test was performed to determine whether 
a difference existed between the two groups. Time to recur-
rence was plotted using the Kaplan–Meier method, and the 
resulting curves were compared between groups using the 
log-rank test. Cox proportional hazard analysis was utilized 
to construct a regression model for the recurrence time and to 
assess the contribution of technique, as well as to adjust for 
patient-demographic factors. Logistic and linear regression 
analyses were performed to model patient-reported improve-
ment in pain and VNS outcome scores, respectively, to adjust 
for the effect of demographic variables in addition to treat-
ment technique. To ensure model validity, interaction effects 
were tested in the regression models, and an examination of 
outliers was performed. Postprocedural complications and the 
need for nonablative follow-up procedures were summarized 
for each group, and a χ2 analysis was performed to compare 
rates of these events between groups.
Results
A total of 373 patients underwent lumbar facet denervation 
between the years of 2008 and 2012. Ninety-four patients 
were treated with the advanced Australian technique, while 
279 patients were treated with the early Australian technique. 
However, 12 patients in the advanced Australian group and 
38 patients in the early Australian group were excluded 
from the inclusion cohort due to lack of data or follow-up. 
Demographic data for the two groups are listed in Table 1. 
The average age was 57.8 and 60.5 years for the advanced 
Australian and early Australian groups, respectively. The 
sex breakdown for these two groups was 41.5% male in the 
advanced Australian group and 36.1% in the early Australian 
group. For all demographic data, no statistically significant 
differences were noted, with the exception of a greater per-
centage of Asian patients in the advanced Australian group 
compared to the early Australian group (P=0.001).
Table 1 Demographic data comparing the Advanced Australian and the Early Australian techniques
Advanced Australian 
technique (82)
Early Australian  
technique (241)
P-value
Ethnicity (n [%]) caucasian 50 (61.0%) 185 (76.8%) 0.01
African-American 4 (4.9%) 22 (9.1%)
asian 16 (19.5%) 3 (1.2%)
hispanic 7 (8.5%) 24 (10.0%)
Middle eastern 5 (6.1%) 7 (2.9%)
Sex (n [%]) Male 34 (41.5%) 87 (36.1%) 0.39
Female 48 (58.5%) 154 (63.9%)
Mean age Years (standard deviation) 57.8 (15.9) 60.5 (15.0) 0.17
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The advanced Australian and early Australian groups 
showed comparable baseline VNS pain scores, 6.45 and 
6.55, respectively, with no statistical difference between the 
two groups (Table 2). Neither the postablative VNS pain 
scores nor the VNS pain-score differences from preablation 
to postablation for the two groups reached a statistically 
significant level based on t-test analysis.
To further assess the efficacy of early Australian and 
advanced Australian techniques on pain relief, a qualitative 
assessment of patients’ self-reported pain relief was  performed. 
Overall, a significantly larger percentage of patients in the 
advanced Australian group reported pain relief (85.4% ver-
sus 70.5%, P=0.012) (Table 2). The need for nonablative 
interventional pain procedures (epidural steroid injections, 
sacroiliac joint injections, piriformis injections) to further treat 
the patient’s pain syndrome was also assessed. The advanced 
Australian group had a slightly higher but not statistically sig-
nificant follow-up procedure rate of 32.9% versus the 27.8% 
of the early Australian group (P=0.38) (Table 2). The majority 
of postablation procedures consisted of an epidural steroid 
injection, a sacroiliac joint injection, or a piriformis injection, 
with 89% and 73% of follow-up procedures consisting of one 
of these three injections in the advanced Australian and early 
Australian groups, respectively.
An assessment of the risk of complications between the 
advanced Australian and early Australian techniques showed 
that complications, including bruising, infection, paresthesias, 
neuritis, and muscle spasms, occurred in roughly 9.8% and 
6.6% of patients in the advanced Australian and early Aus-
tralian groups, respectively (P=0.37). To better assess the risk 
of postdenervation neuritis, a χ2 analysis of this single com-
plication was performed, with both groups showing similar 
occurrence rates of 3.7% and 2.5% (P=0.58) (Table 2).
In addition to analysis of initial pain relief obtained 
from undergoing a lumbar facet denervation for the treat-
ment of lumbar facet pain, the duration of relief was 
measured. In the advanced Australian group, 62 of 82 
(75.7%) patients had documented recurrence of their 
pain, while 208 of 241 (82.3%) of patients in the early 
Australian group had documented recurrence of their 
pain. A Kaplan–Meier curve was plotted to assess sta-
tistical difference between the two groups (Figure 1). 
Immediate procedural treatment failure was higher in the 
early Australian group, with 50% of all patients in this group 
showing initial recurrence of pain by 1.5 months. In contrast, 
the advanced Australian group showed that 50% of patients 
continued to remain pain-free until 4 months. This difference 
in duration of treatment effect was statistically significant 
(P=0.022). However, by 11 months postprocedure, the dif-
ference in pain relief between the advanced Australian and 
Table 2 Analysis of primary and secondary outcome measures
Advanced Australian 
technique (82)
Early Australian  
technique (241)
P-value
Vns dataa Preablation Mean VNS 6.45 (1.77) 6.55 (1.78) 0.72
Preablation Median VNS 7 (5–8) 7 (5–8)
Postablation Mean VNS 3.64 (2.41) 4.27 (2.71) 0.06
Postablation Median VNS 3.75 (1.75–5) 4 (2–6)
Mean Vns difference 2.82 (2.30) 2.28 (2.54) 0.08
Median Vns difference 3 (1–6) 2.5 (0–6)
Benefit (n [%])b Yes 70 (85.4%) 170 (70.5%) 0.012
Reliefc Median duration (months) 4.0 (2,6) 1.5 (1,2) 0.022
Complications (n [%])d All complications (events) 8 (9.8%) 16 (6.6%) 0.37
Neuritis (events) 3 (3.7%) 6 (2.5%) 0.58
Follow-up procedure (n [%])d Yes 27 (32.9%) 67 (27.8%) 0.38
Notes: aa t-test analysis was used to compare pre- and postablation VNS score changes, as well as VNS score differences between the advanced Australian and early 
Australian techniques; bbenefit reported between the advanced Australian and early Australian groups assessed using χ2 analysis; cduration of relief between the two treatment 
groups assessed using log-rank analysis; dcomparison of complications and need for follow-up procedures was assessed using χ2 analysis.
Abbreviation: VNS, visual numeric scale.
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Figure 1 Kaplan–Meier curve showing failure rate over time in months between the 
advanced Australian and early Australian groups.
Note: a statistically significant difference between the two groups was determined 
based on a P-value of 0.022 calculated using a log-rank test.
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early Australian groups became negligible, with nearly 90% 
of all patients in both groups reporting recurrence of their 
pain to preablation levels.
The effects of demographic variables influencing the 
duration of pain relief were assessed using a Cox propor-
tional hazard model (Table 3). Of the demographic factors 
analyzed, only the treatment group showed a significant dif-
ference (P=0.01). The effect of treatment group showed that 
the advanced Australian technique was associated with less 
failure to treat for patients undergoing a lumbar facet dener-
vation procedure, with a hazard ratio of 0.83 (95% confidence 
interval [CI] 0.71–0.96). The effects of age, sex, ethnicity, 
preablation VNS pain score, and pain-medication consump-
tion were all statistically nonsignificant.
A linear regression analysis evaluating variables’ effect on 
postablation VNS scores was performed, with age, sex, preabla-
tion VNS pain score, and pain-medication usage showing impor-
tance. Sex, preablation VNS pain score, and pain-medication 
usage showed statistical significance, while age demonstrated 
near-statistical significance (Table 4). Age and preablation 
VNS demonstrated a positive correlation with postablation 
VNS scores, with increases in age and preablation VNS scores 
resulting in increased postablation scores. Sex and preablation 
pain-medication use had a negative correlation with postablation 
VNS scores, with male sex and no pain-medication use being 
associated with a decreased postablation VNS score (Table 4).
A logistic regression analysis revealed that age and treat-
ment group were significantly associated with patient self-
reported procedural benefit (Table 5). Age demonstrated a 
positive correlation with patient self-reported benefit, with an 
odds ratio of 1.02 (95% CI 1.00–1.04), indicating a greater 
chance of subjective patient-reported benefit as patients 
became older. The effect of treatment group on outcome dem-
onstrated that the advanced Australian technique produced 
better patient-reported outcomes, with an odds ratio of 1.46 
(95% CI 1.04–2.06). To assess the prediction accuracy of the 
logistic regression analysis, a receiver operating characteristic 
curve was plotted, with a calculated area under the curve of 
0.6138 (Figure 2).
Discussion
Currently, no comparative studies exist evaluating the effi-
cacy and safety of different lumbar facet joint-denervation 
needle-placement techniques for the treatment of lumbar 
facet arthropathy pain. A study by Lau et al demonstrated 
the anatomic pathway of medial branch nerve innervation 
for the lumbar facet joints, arguing that parallel placement 
(advanced Australian technique) of the radiofrequency probes 
Table 3 Cox proportional hazard analysis for individual variables 
and their effect on recurrence of patient pain
Factors Category Hazard ratio (95% 
confidence interval)
P-value
Age (years) 1.00 (0.99, 1.01) 0.77
Sex (male) Male 0.99 (0.87, 1.13) 0.91
Ethnicity (Caucasian) caucasian 0.96 (0.84, 1.11) 0.55
Treatment group 
(Advanced Australian)
advanced 
australian
0.83 (0.71, 0.96) 0.01
Preablation VNS 1.04 (0.97, 1.12) 0.25
Pain medication (No) no 0.91 (0.78, 1.06) 0.23
Abbreviation: VNS, visual numeric scale.
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Figure 2 logistic regression receiver operating characteristic curve. area under the 
curve calculated to be 0.6138.
Notes: The gray line is the control line for uniformative ROC curve. The blue line 
represents the ROc curve for predictive value of our logistic regression model.
Table 4 Linear regression model with postablation VNS pain 
score as the outcome measure
Factors Coefficient  
(standard error)
P-value
Age (years) 0.02 (0.01) 0.08
Sex (male) -0.31 (0.15) 0.03
Preablation VNS 0.58 (0.08) <0.01
Pain-medication use (n) -0.41 (0.17) 0.02
Treatment group (Advanced 
Australian)
-0.20 (0.17) 0.22
Abbreviation: VNS, visual numeric scale.
Table 5 Logistic regression model with patient self-reported 
procedural benefit as the outcome measure
Factors Odds ratio (95%  
confidence interval)
P-value
Age (Years) 1.02 (1.00, 1.04) 0.04
Group (Advanced Australian) 1.46 (1.04, 2.06) 0.03
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against the medial branch nerves is key to successful treat-
ment of facet arthropathy.18 Based on the anatomic finding 
in this study, Lau et al18 hypothesized that many lumbar 
facet denervation techniques fail to appropriately ablate the 
nervous innervation to the lumbar facet joints, as they are 
not placed parallel to the medial branch nerves. A recent 
review by Gofeld and Faclier also supported an anatomically 
appropriate radiofrequency needle-placement technique 
and reported on the paucity of research available using the 
correct anatomic technique.19 The goal of the current study 
was retrospectively to evaluate and validate the hypothesis 
that the advanced Australian technique is superior to the 
early Australian technique based on the anatomic findings 
of Lau et al.18
In the present study, the magnitude and duration of 
pain relief reported by patients were found to be greater 
in patients treated with the advanced Australian versus the 
early Australian technique. This outcome is consistent with 
the findings detailed in a study by Dreyfuss et al.12 However, 
Dreyfuss et al12 demonstrated prolonged benefit with the 
use of the advanced Australian technique in appropriately 
selected patients. The present study failed to replicate the 
lasting beneficial effects seen within the Dreyfuss et al12 
study, as patients demonstrated median initial recurrence of 
pain by 1.5 months and 4 months within the early  Australian 
and advanced Australian groups, respectively. By 12 months, 
90% of patients in both groups demonstrated recurrence of 
their pain to preablation levels (Figure 1), which is noticeably 
different than the 60%–80% of patients that continued to 
experience pain relief at 12 months within the Dreyfuss et al 
study.12 While the duration of pain relief in the two groups was 
shorter compared to this study, the pain relief obtained for 
both groups was clinically beneficial. Both groups experi-
enced a decrease in VNS pain scores of greater than 2 points, 
which is a clinically relevant result,21 though the change in 
VNS scores between the two groups did not reach a statisti-
cally significant difference.
Possible explanations for the lack of prolonged benefit 
experienced by patients in this study are: 1) performance 
of the procedure in a teaching institution, 2) the possibil-
ity of false-positive diagnostic blockade associated with 
single medial branch blocks,22 3) the multifactorial nature 
of low-back pain, and 4) aberrant nerve sprouting. Clinical 
studies for diagnostic blocks for facet joint pain have 
reported a high incidence of false-positive results, with up 
to 41% incidence in the lumbar spine.12,23,24 Multiple factors 
can account for such a high false-positive rate, including 
a high rate of response to placebo injections,25 inappropri-
ate use of sedation26 or superficial local anesthetic,27 and 
spread of the injectate to other structures that can generate 
pain.28,29 Therefore, false-positive responses to diagnostic 
medial branch blocks could potentially explain our results. 
Furthermore, the causes of low-back pain range from facet 
arthropathy, spinal stenosis, and radiculopathies to muscular 
and fascial etiologies. In many patients, facet arthropathy, 
spinal stenosis, and lumbar radiculopathy coexist. Therefore, 
the presence of comorbidities results in only partial treat-
ment of a patient’s low-back pain. In the present study, the 
presence of comorbidities could potentially explain the lack 
of prolonged benefit and immediate failure rates of 12.8% 
and 25.4% in the advanced Australian and early Australian 
groups, respectively. Okuyama et al showed that radiofre-
quency ablation in cardiac tissue results in aberrant nerve 
sprouting within 2 hours after ablation. Therefore, ablation 
of nerves within the back has a high likelihood for a similar 
development, which could cause faster failure rates.30
With regard to the demographic differences between the 
advanced Australian and early Australian groups, the only 
significant difference was the ethnic groups represented. 
The advanced Australian group had an Asian population of 
19% versus 1.1% in the early Australian group (P=0.001). 
However, the outcomes observed were not influenced by 
ethnicity. Results of the Cox proportional hazard model 
showed that only the treatment group significantly affected 
the recurrence rate of a patient’s pain (P=0.01), with ethnic-
ity having a P-value of 0.55. A linear regression analysis 
modeled on postablation VNS scores only showed age, sex, 
preablation VNS score, and pain medication as significant 
factors. Similarly, a logistic regression analysis found age 
and treatment group to be significantly correlated with patient 
pain relief. Therefore, while the ethnic breakdown between 
groups was statistically different, this difference did not affect 
the outcomes observed.
Within the linear regression analysis, age and preabla-
tion VNS score had a positive correlation with increased 
postprocedural VNS scores. The lumbar spine of an aging 
individual is subject to increased degenerative processes, 
which increase the likelihood for the development and 
potential severity of low-back pain. Therefore, clinically, 
one could anticipate that the treatment of facet arthropathy 
may be more difficult in elderly patients as they have more 
potential sources for pain, resulting in higher postablation 
VNS scores. Similarly, if the ablative procedure confers 
the same degree of benefit within individuals, an individual 
with a higher preablation VNS score will likely have higher 
postablation VNS scores. However, in practice, this may not 
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always be true, as appropriate treatment in those with a higher 
initial VNS score could give rise to a greater appreciation of 
pain relief and thus a lower pain score.
In contrast to the linear regression analysis, the logistic 
regression analysis found that only age and treatment group 
significantly impacted whether patients subjectively reported 
benefit from their lumbar facet denervation procedure. 
Increasing age was associated with an increased likelihood 
of patient-reported benefit, which is an interesting finding, 
considering that increased age was associated with increased 
postablative VNS pain scores in the linear regression analysis. 
Therefore, while older patients had higher postablative VNS 
scores, they also reported more benefit from denervation of 
their lumbar facet joints. This finding may suggest that the 
elderly, despite their higher postablative pain scores, can 
derive noticeable improvement in their overall condition 
after facet denervation. In the advanced Australian technique 
group, the odds ratio for patient self-reported procedural 
benefit was 1.46 times that of the early Australian technique. 
This finding further supports the hypothesis and anatomic 
studies that suggest the superiority of the advanced Australian 
technique over the early Australian technique.
Sex also appeared to play a role based on the Cox pro-
portional hazard analysis, with male sex conferring a better 
outcome (hazard ratio 0.99). Therefore, within the linear 
regression analysis, the decrease in postablation VNS score of 
0.312 for being male appears clinically appropriate. Similar 
to sex, patients not using pain medication had a hazard ratio 
of 0.91 measured by Cox proportional hazard analysis, com-
pared to patients that did require use of pain medications. 
Therefore, it is logical that the linear regression-analysis out-
come showing that patients who did not take pain medication 
at baseline had a postablation VNS score 0.408 points lower 
than in patients who did use pain medications at baseline.
In addition to evaluating the benefits of the advanced 
Australian and early Australian techniques in the treatment of 
lumbar facet pain, the safety of these two techniques was also 
assessed. The risk of complications was clinically significant, 
with both groups having a complication rate between 5% and 
10%. The two groups did not have a statistically significant 
difference in rate of complications based on χ2 analysis. 
While the advanced Australian technique is associated with 
closer placement of the radiofrequency ablative near the 
medial and dorsal branches of the nerve roots of the spine, 
the risk of postablative neuritis was not statistically different 
between the two groups.
Patient selection and technical factors can play a sig-
nificant confounding role in the results of such a study as 
this. Given the study’s retrospective nature, all the possible 
individual provider and patient factors that can affect 
patient selection and radiofrequency technique could not 
be controlled. By itself, radiofrequency technique can 
provide a difference in lesion volumes depending on the 
size of the radiofrequency cannula, the length of the active 
tip, the temperatures used, and the use of fluid modulation 
prior to lesioning. In our practice, there is uniformity among 
the providers with regard to using similar temperatures 
(80°C–90°C), use of 1 mL 1% lidocaine as fluid modulation 
prior to lesioning, and all providers using 18- to 20-gauge 
needles all with a 10 mm active tip. Due to the uniformity 
of technique in our practice, the main difference in radiof-
requency technique lies in the differing needle-placement 
techniques. This reduces but does not completely negate 
the possibility that patient-selection differences between 
providers or another aspect of radiofrequency technique are 
significantly confounding the results.
In conclusion, this retrospective study compared the effi-
cacy and safety of the early Australian and advanced Australian 
facet radiofrequency-ablation techniques. The results of this 
study not only support the use of facet radiofrequency ablation 
in treatment of lumbar facet arthropathy due to improvement in 
pain scores and patient self-reported benefit but also strongly 
support the use of the anatomically correct advanced Australian 
technique when performing this procedure. Further large-scale, 
double-blind, randomized controlled trials evaluating efficacy 
using the advanced Australian technique are warranted to 
confirm the findings found in the present study.
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